Allergy Treatment Progress in Regeneron’s Immunology Pipeline
Regeneron Pharmaceuticals is rapidly advancing allergy treatment and immunology research. Moreover, the company highlighted a strong pipeline of innovative therapies at the 2026 AAAAI annual meeting.The expanding portfolio includes novel Phase 3 allergen-specific a.. Read the news
